UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

All-Assay-Max2 pQSAR: Activity Predictions as Accurate as Four-Concentration IC50s for 8558 Novartis Assays

Journal of chemical information and modeling, 2019-10, Vol.59 (10), p.4450-4459

2019

Volltextzugriff (PDF)

Profile-QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four-Concentration IC50s for Realistically Novel Compounds

Journal of chemical information and modeling, 2017-08, Vol.57 (8), p.2077-2088

2017

Volltextzugriff (PDF)

Indexing Ultrafast Shape-Based Descriptors in MongoDB to Identify TLR4 Pathway Agonists

Journal of chemical information and modeling, 2022-05, Vol.62 (10), p.2446-2455

2022

Volltextzugriff (PDF)

Building Machine Learning Small Molecule Melting Points and Solubility Models Using CCDC Melting Points Dataset

Journal of chemical information and modeling, 2023-05, Vol.63 (10), p.2948-2959

2023

Volltextzugriff (PDF)

Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF

Cancer research (Chicago, Ill.), 2018-03, Vol.78 (6), p.1537-1548

2018

Volltextzugriff (PDF)

Web services as applications' integration tool: QikProp case study

Journal of computational chemistry, 2011-07, Vol.32 (9), p.1944-1951

2011

Volltextzugriff (PDF)

All-Assay-Max2 pQSAR: Activity Predictions as Accurate as Four-Concentration IC 50 s for 8558 Novartis Assays

Journal of chemical information and modeling, 2019-10, Vol.59 (10), p.4450-4459

2019

Volltextzugriff (PDF)

Profile-QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four-Concentration IC 50 s for Realistically Novel Compounds

Journal of chemical information and modeling, 2017-08, Vol.57 (8), p.2077-2088

2017

Volltextzugriff (PDF)

X‐ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan–McDermid Syndrome

ChemMedChem, 2018-09, Vol.13 (18), p.1997-2007

2018

Volltextzugriff (PDF)

Enrichment Analysis for Discovering Biological Associations in Phenotypic Screens

Journal of chemical information and modeling, 2014-02, Vol.54 (2), p.377-386

2014

Volltextzugriff (PDF)

Acoustic conductance of a thick-walled anisotropic spherical shell submerged in liquid

Aviation (Vilnius, Lithuania), 2014-01, Vol.18 (1), p.52-55

2014

Volltextzugriff (PDF)

Over 14-year survival of pressed e.max lithium disilicate glass-ceramic complete and partial coverage restorations in patients with severe wear: A prospective clinical study

The Journal of prosthetic dentistry, 2024-07

2024

Volltextzugriff (PDF)

Incidence of endodontic therapy after complete or partial coverage glass-ceramic restorations with a follow-up time of over 30 years: A prospective clinical study

The Journal of prosthetic dentistry, 2023-01, Vol.129 (1), p.49-60

2023

Volltextzugriff (PDF)

Design and Discovery of N‑(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the Clinic

Journal of medicinal chemistry, 2020-03, Vol.63 (5), p.2013-2027

2020

Volltextzugriff (PDF)

Profile-QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four-Concentration IC^sub 50^s for Realistically Novel Compounds

Journal of chemical information and modeling, 2017-08, Vol.57 (8), p.2077

2017

Volltextzugriff (PDF)

Decision support systems in drug discovery

Mini reviews in medicinal chemistry, 2004-12, Vol.4 (10), p.1019-1028

2004

Volltextzugriff (PDF)

Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria

Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3309-3324

2018

Volltextzugriff (PDF)

Design and Discovery of N‑(2-Methyl-5′-morpholino-6′-((tetrahydro‑2H‑pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers

Journal of medicinal chemistry, 2017-06, Vol.60 (12), p.4869-4881

2017

Volltextzugriff (PDF)

FOCUS  Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists

Journal of chemical information and modeling, 2015-04, Vol.55 (4), p.896-908

2015

Volltextzugriff (PDF)

Synthesis, characterization, and molecular structure of a gallium(III) complex of an amine-phenol ligand with activity against chloroquine-sensitive Plasmodium falciparum strains

Journal of inorganic biochemistry, 2003-01, Vol.93 (3), p.265-270

2003

Volltextzugriff (PDF)

Abstract DDT01-04: Pharmacological profile and anti-tumor properties of LXH254, a highly selective RAF kinase inhibitor

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.DDT01-04-DDT01-04

2018

Volltextzugriff (PDF)

Abstract 330: Development of a highly selective B/CRAF kinase inhibitor that exhibits antitumor activities in RAS and BRAF mutant tumors with minimal paradoxical activation

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.330-330

2016

Volltextzugriff (PDF)

Abstract 330: Development of a highly selective BCRAF kinase inhibitor that exhibits antitumor activities in RAS and BRAF mutant tumors with minimal paradoxical activation

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.330-330

2016

Volltextzugriff (PDF)

Visualization Lecture in the Digital Educational Process at the University

Advances in Digital Science, p.138-148

Volltextzugriff (PDF)

Synthesis, Molecular Structure, and Properties of a Neutral Schiff Base Phenolic Complex of Magnesium

Inorganic chemistry, 1998-09, Vol.37 (18), p.4740-4742

1998

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

All-Assay-Max2 pQSAR: Activity Predictions as Accurate as Four-Concentration IC50s for 8558 Novartis Assays

Profile-QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four-Concentration IC50s for Realistically Novel Compounds

Indexing Ultrafast Shape-Based Descriptors in MongoDB to Identify TLR4 Pathway Agonists

Building Machine Learning Small Molecule Melting Points and Solubility Models Using CCDC Melting Points Dataset

Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF

Web services as applications' integration tool: QikProp case study

All-Assay-Max2 pQSAR: Activity Predictions as Accurate as Four-Concentration IC 50 s for 8558 Novartis Assays

Profile-QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four-Concentration IC 50 s for Realistically Novel Compounds

X‐ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan–McDermid Syndrome

Enrichment Analysis for Discovering Biological Associations in Phenotypic Screens

Acoustic conductance of a thick-walled anisotropic spherical shell submerged in liquid

Over 14-year survival of pressed e.max lithium disilicate glass-ceramic complete and partial coverage restorations in patients with severe wear: A prospective clinical study

Incidence of endodontic therapy after complete or partial coverage glass-ceramic restorations with a follow-up time of over 30 years: A prospective clinical study

Design and Discovery of N‑(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the Clinic

Profile-QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four-Concentration IC^sub 50^s for Realistically Novel Compounds

Decision support systems in drug discovery

Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria

Design and Discovery of N‑(2-Methyl-5′-morpholino-6′-((tetrahydro‑2H‑pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers

FOCUS  Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists

Synthesis, characterization, and molecular structure of a gallium(III) complex of an amine-phenol ligand with activity against chloroquine-sensitive Plasmodium falciparum strains

Abstract DDT01-04: Pharmacological profile and anti-tumor properties of LXH254, a highly selective RAF kinase inhibitor

Abstract 330: Development of a highly selective B/CRAF kinase inhibitor that exhibits antitumor activities in RAS and BRAF mutant tumors with minimal paradoxical activation

Abstract 330: Development of a highly selective BCRAF kinase inhibitor that exhibits antitumor activities in RAS and BRAF mutant tumors with minimal paradoxical activation

Visualization Lecture in the Digital Educational Process at the University

Synthesis, Molecular Structure, and Properties of a Neutral Schiff Base Phenolic Complex of Magnesium

Suchergebnisse filtern